TY - JOUR
T1 - Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma
AU - Sato, Hiromichi
AU - Hara, Tomoaki
AU - Tatekawa, Shotaro
AU - Sasaki, Kazuki
AU - Kobayashi, Shogo
AU - Kitagawa, Toru
AU - Doki, Yuichiro
AU - Eguchi, Hidetoshi
AU - Ogawa, Kazuhiko
AU - Uchida, Shizuka
AU - Ishii, Hideshi
N1 - Copyright © 2022 Sato, Hara, Tatekawa, Sasaki, Kobayashi, Kitagawa, Doki, Eguchi, Ogawa, Uchida and Ishii.
PY - 2022/11/14
Y1 - 2022/11/14
N2 - An international project on the human genome revealed that various RNAs (e.g., messenger RNAs, microRNAs, and long noncoding RNAs [lncRNAs] and their subclass circular RNA [circRNA)) are involved in the pathogenesis of different human diseases, including cancer. Recent studies have highlighted the critical roles of lncRNAs and circRNA in pancreatic ductal adenocarcinoma (PDAC), especially in the epithelial–mesenchymal transition, a phenomenon regulating cancer metastasis. Growing research in this field has indicated that the tertiary structure of lncRNAs supposedly regulates biological function via RNA–RNA or RNA–protein associations, aiding early diagnosis and therapy selection for various diseases, including cancer. Here we describe the emerging roles of ncRNAs in PDAC and highlight how these ncRNAs can be used to detect and control this intractable cancer.
AB - An international project on the human genome revealed that various RNAs (e.g., messenger RNAs, microRNAs, and long noncoding RNAs [lncRNAs] and their subclass circular RNA [circRNA)) are involved in the pathogenesis of different human diseases, including cancer. Recent studies have highlighted the critical roles of lncRNAs and circRNA in pancreatic ductal adenocarcinoma (PDAC), especially in the epithelial–mesenchymal transition, a phenomenon regulating cancer metastasis. Growing research in this field has indicated that the tertiary structure of lncRNAs supposedly regulates biological function via RNA–RNA or RNA–protein associations, aiding early diagnosis and therapy selection for various diseases, including cancer. Here we describe the emerging roles of ncRNAs in PDAC and highlight how these ncRNAs can be used to detect and control this intractable cancer.
U2 - 10.3389/fphys.2022.1025923
DO - 10.3389/fphys.2022.1025923
M3 - Journal article
C2 - 36452037
VL - 13
JO - Frontiers in Physiology
JF - Frontiers in Physiology
SN - 1664-042X
ER -